AdAlta’s CEO and Managing Director, Dr Tim Oldham is attending ANZ Biologics Festival 2026 where he will present a paper titled “Increasing patient access to CAR-T cell therapies in Australia and SE Asia” in which he:

• Outlines the current barriers that exist for patients to maximise access to CAR-T cell therapies

• Proposes a blueprint to improve that access

• Highlights how AdCella’s “East to West” cellular immunotherapy strategy is aligned with this blueprint to bring these ground breaking therapies to more Australian and SE Asian patients